Healio Minute Wednesday, Aug. 28, 2013 Edition: FDA revisits drugs and breast feeding, many clinician visits begin with an itch, subcutaneous defibrillator shows promise
What just happened in medicine and why do you care?
New FDA breast-feeding guidelines take a second look at drug impacts
Healio.com/Pediatrics: More detailed labeling is designed to help mothers weigh risks to infants without ignoring benefits of continued nursing. Read more.
Turns out many ambulatory care visits start with an itch, literally

Healio.com/Dermatology: US clinicians often face the challenge of managing a host of high-frequency itch categories, according to a decade of data. Read more.
Subcutaneous defibrillator gets good grades in initial trials
Healio.com/Cardiology: Device effectively treats life-threatening ventricular arrhythmias in multi-center trial, although 13% of patients received inappropriate shocks. Read more.
Antipsychotic drug use drops 9% among nursing home residents
Healio.com/Psychiatry: Awareness program shows promising results in less than two years. Read more.
Most men still favor PSA testing despite possible downsides
Healio.com/Hematology-Oncology: Snapshot of men’s attitudes reveal that any negative message about cancer screening may just seem counterintuitive. Read more.